A COVID-19 patient in Melbourne as part of a series of tests to map her wide range of immune responses to coronavirus, offering information on the capacity of the body to combat the pneumonia-causing pathogen.
Blood tests examined at four separate points of time revealed that the 47-year-old woman produced white blood cells that killed virus-infected cells and triggered the development of antibodies that accelerated her recovery 10 days after contracting a mild to moderate disease that needed hospitalisation.
Her case, published in the journal Nature Medicine on Monday. A number of others examined by researchers at the Peter Doherty Institute for Infection and Immunity in Melbourne. It helps to classify trends of the immune system. It may help doctors diagnose one-in-five patients likely to develop a serious or critical type of COVID-19.
The woman had travelled from the central Chinese city of Wuhan and became ill in Melbourne. Talking about the blood test, she revealed that, in reaction to the novel coronavirus. She said that she developed some inflammation but not the potentially fatal, out-of-control type that can kill healthy tissues.
Once her symptoms resolved, Kedzierska and his colleagues found antibodies to the COVID-19 virus in the patient’s blood. Also, the investigators are now focusing on recognizing the infection’s “immunological memory.”
So, this will include information as to whether the patient’s reaction to the antibody. It is to see if it is adequate to protect her from subsequent infection, but if so, for how long.